## CPT: Camden Property Trust - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 2.3% below STRENGTH zone (3.0-6.0%); PEG 8.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($101.27)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 1)

**1. Is Camden Property Trust Stock Underperforming the Nasdaq?**
- Source: Markets Financial Content | 20251216T025900 | Somewhat-Bearish | Relevance: 100%
- Camden Property Trust (CPT) has seen its stock decline significantly from its 52-week high, underperforming the Nasdaq Composite over the past three months, year-to-date, and over the past year. Despite a positive reaction to its Q3 results and outperforming a peer, the stock shows a bearish trend. Analysts hold a "Moderate Buy" rating with an 11.4% upside potential.

**2. Truist Financial Cuts Camden Property Trust (NYSE:CPT) Price Target to $116.00**
- Source: MarketBeat | 20251215T145504 | Somewhat-Bearish | Relevance: 100%
- Truist Financial has lowered its price target for Camden Property Trust (NYSE:CPT) to $116.00 from $123.00, while reiterating a "buy" rating, indicating a potential upside of 10.97%. Other analysts have also adjusted their targets, resulting in a MarketBeat consensus "Hold" rating and an average price target of $117.57 for CPT. Camden Property Trust recently reported strong Q3 earnings, slightly beating estimates, and provided positive FY2025 guidance.

**3. Truist Financial Maintains Camden Property Trust(CPT.US) With Buy Rating, Announces Target Price $116**
- Source: 富途牛牛 | 20251215T140805 | Bullish | Relevance: 100%
- Truist Financial analyst Michael Lewis has maintained a "Buy" rating on Camden Property Trust (CPT.US) and set a target price of $116. This evaluation is based on TipRanks data, indicating the analyst's successful track record and average return over the past year.

**4. Camden Property Trust (CPT): Reassessing Valuation After Q3 Earnings Beat and Upgraded Funds From Operations Guidance**
- Source: Simply Wall Street | 20251214T160807 | Somewhat-Bullish | Relevance: 100%
- Camden Property Trust (CPT) has beaten Q3 earnings expectations and upgraded its full-year funds from operations guidance, prompting a re-evaluation of its stock. Despite a negative year-to-date return, the company is seen by some as 11% undervalued, with a fair value of $116.67, driven by strong apartment demand and improving affordability. However, others view its current valuation as potentially pricey given its high P/E ratio compared to peers.

**5. Camden Property Trust (CPT): Reassessing Valuation After Q3 Earnings Beat and Upgraded Funds From Operations Guidance**
- Source: Simply Wall Street | 20251214T153902 | Somewhat-Bullish | Relevance: 100%
- Camden Property Trust (CPT) recently released strong Q3 earnings, exceeding expectations and raising its full-year funds from operations guidance. Despite this positive news and reaffirmed dividends, the stock has seen a negative year-to-date return, suggesting a stabilization rather than a surge in sentiment. While narratives suggest CPT is 11% undervalued with a target fair value of $116.67, driven by strong apartment demand and moderating supply, an alternative view highlights its high price-to-earnings ratio compared to peers, suggesting limited room for error if growth falters.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Truist Securiti | $116 | $123 | -6% |
| 2025-11-25 | Wells Fargo | $110 | $111 | -1% |
| 2025-11-25 | Barclays | $118 | $127 | -7% |
| 2025-11-24 | Mizuho | $114 | $115 | -1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Truist Securiti | main | Buy |
| 2025-11-25 | Wells Fargo | main | Equal-Weight |
| 2025-11-25 | Barclays | down | Equal-Weight |
| 2025-11-24 | Mizuho | main | Outperform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 56.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 16.0% (-0.5%)
- Blackrock Inc.: 10.8% (+3.2%)
- State Street Corpora: 7.1% (+1.5%)
- FMR, LLC: 5.1% (+17.5%)
- Viking Global Invest: 3.6% (+41.6%)

### Key Risks

1. Valuation stretched: PEG 9.0x requires aggressive growth execution.
2. Long-term trend broken: trading 5.7% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +6.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 8.96 signals overvaluation risk, limited margin of safety. Forward P/E 78.3x stretched relative to 17% growth. Quality metrics strong (margin 17%). Analyst sentiment negative (4 target cuts vs 0 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.2B |
| Beta | 0.82 |
| 52W Range | $97.17 - $126.55 |
| Short Interest | 3.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 8.96 |
| Forward P/E | 78.3 |
| Current P/E | 91.8 |
| YoY Growth | 17.4% |
| EPS Direction | None |

### Technicals

MRS_10 strengthening from -3.8% to 2.3% (+6.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.7pp (needs >3.0% for momentum thesis). MRS_5 at 2.6% confirms short-term momentum alignment. Below SMA200 (0.94x), long-term trend not supportive. RSI neutral at 54. OFD pattern: -DLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.31% (CS: 52) | Neutral |
| RSI_14 | 53.8 | Neutral |
| MACD Histogram | -0.09 | Bearish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 1.016x | Above |
| vs SMA200 | 0.943x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $104.65
- **Stop Loss:** $101.27 (3.2% risk)
- **Target:** $108.03 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 295
- **Position Value:** $30,871.75
- **Portfolio %:** 30.87%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-05 (Est: $0.28)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.28 | $0.21 | -23.2% |
| 2025Q2 | $0.33 | $0.31 | -6.9% |
| 2025Q1 | $0.28 | $0.36 | +29.5% |
| 2024Q4 | $0.42 | $0.37 | -11.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*